TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | 11 | 18 | 41 | 64 | 106 | 274 | 86 |
| P | %wins | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/1/20 16:06 | 9/30/20 | BDTX | Black Diamond Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Ingram Robert Alexander | MA | D | P | 152 | 30.46 | 0 | 5 | New | 5 | D | |||||||||||||||
11/18/19 16:12 | 11/18/19 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Ingram Robert Alexander | NC | D | P | 29 | 1.45 | 0 | 20 | 71 | 48 | D | |||||||||||||||
5/23/19 08:31 | 5/22/19 | NOVN | Novan, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Ingram Robert Alexander | NC | D | P | 111 | 2.21 | 0 | 50 | 42 | 170 | D | |||||||||||||||
10/1/18 16:34 | 9/28/18 | NOVN | Novan, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Ingram Robert Alexander | NC | D | P | 142 | 2.84 | 0 | 50 | 72 | 120 | D | |||||||||||||||
8/29/17 16:37 | 8/25/17 | NOVN | Novan, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Ingram Robert Alexander | NC | D | P.m | 55 | 4.57 | 0 | 12 | 21 | 70 | D | |||||||||||||||
3/10/09 10:46 | 3/6/09 | CREE | Cree Inc | NC | Tech | Semicn | Semiconductors & Related Devi | Ingram Robert Alexander | NC | D | P | 19 | 18.95 | 22 | 1 | 27 | 5 | 11 | 18 | 41 | 64 | 106 | 274 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |